(Q43868957)

27 November 2017

title

Discovery of a nonpeptidic small molecule antagonist of the human platelet thrombin receptor (PAR-1). (English)

1 reference

27 November 2017

2

1 reference

27 November 2017

Philippe G Nantermet

1

1 reference

27 November 2017

George F Lundell

3

1 reference

27 November 2017

Janetta M Pellicore

4

1 reference

27 November 2017

Kenneth E Rittle

5

1 reference

27 November 2017

MaryBeth Young

6

1 reference

27 November 2017

Roger M Freidinger

7

1 reference

27 November 2017

Thomas M Connolly

8

1 reference

27 November 2017

Cindra Condra

9

1 reference

27 November 2017

Jerzy Karczewski

10

1 reference

27 November 2017

Rodney A Bednar

11

1 reference

27 November 2017

Stanley L Gaul

12

1 reference

27 November 2017

Robert J Gould

13

1 reference

27 November 2017

Kris Prendergast

14

1 reference

27 November 2017

Harold G Selnick

15

1 reference

27 November 2017

language of work or name

English

0 references

publication date

1 February 2002

1 reference

Bioorganic & Medicinal Chemistry Letters

27 November 2017

published in

1 reference

27 November 2017

volume

12

1 reference

27 November 2017

issue

3

1 reference

27 November 2017

page(s)

319-323

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900745-4

27 November 2017

1 reference

7 January 2021

Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900745-4

7 January 2021

Protease activated receptors: theme and variations

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900745-4

7 January 2021

Thrombin signalling and protease-activated receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900745-4

7 January 2021

Review article: proteinase-activated receptors - novel signals for gastrointestinal pathophysiology

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900745-4

7 January 2021

How the protease thrombin talks to cells

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900745-4

7 January 2021

Proteinase-activated receptors: novel mechanisms of signaling by serine proteases.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900745-4

7 January 2021

The protease-activated receptors and their cellular expression and function in blood-related cells

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900745-4

7 January 2021

Cellular consequences of thrombin-receptor activation

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900745-4

7 January 2021

Protease-activated receptors start a family

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900745-4

7 January 2021

Proteinase-activated receptors: a growing family of heptahelical receptors for thrombin, trypsin and tryptase

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900745-4

7 January 2021

Inhibition of arterial thrombosis by a peptide ligand of the thrombin receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900745-4

7 January 2021

Protease-activated receptors: sentries for inflammation?

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900745-4

7 January 2021

Protease-activated receptor-2 modulates myocardial ischemia-reperfusion injury in the rat heart

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900745-4

7 January 2021

Development of a potent thrombin receptor ligand

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900745-4

7 January 2021

Design, synthesis, and biological characterization of a peptide-mimetic antagonist for a tethered-ligand receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900745-4

7 January 2021

Heterocycle-peptide hybrid compounds. Aminotriazole-containing agonists of the thrombin receptor (PAR-1).

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900745-4

7 January 2021

Development of potent thrombin receptor antagonist peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900745-4

7 January 2021

Discovery and optimization of a novel series of thrombin receptor (par-1) antagonists: potent, selective peptide mimetics based on indole and indazole templates

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900745-4

7 January 2021

Structure-activity relationships of pyrroloquinazolines as thrombin receptor antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900745-4

7 January 2021

A comparative SAR study of thrombin receptor derived non peptide mimetics: importance of phenyl/guanidino proximity for activity

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900745-4

7 January 2021

In vitro antiplatelet profile of FR171113, a novel non-peptide thrombin receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900745-4

7 January 2021

Discovery and initial structure-activity relationships of trisubstituted ureas as thrombin receptor (PAR-1) antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900745-4

7 January 2021

Isoxazole derivatives as centrally acting muscle relaxants. III. Synthesis and activity of conformationally restricted analogs.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900745-4

7 January 2021

An antibody against the exosite of the cloned thrombin receptor inhibits experimental arterial thrombosis in the African green monkey

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2801%2900745-4

7 January 2021

10.1016/S0960-894X(01)00745-4

Identifiers

DOI

1 reference

27 November 2017

1 reference